Tag: Robert R. Rando

Harvard Medical School announced May 23, 2006 that is has signed a multimillion-dollar license agreement with Merck & Co. Inc. to develop potential therapies for macular degeneration, an eye disease that affects older people and can lead to blindness. The agreement provides Merck, through an affiliate, with licenses to specific molecules that could ultimately slow…